FDA temporarily suspends order banning Juul cigarettes

By AP News

Share:

WASHINGTON (AP) — The Food and Drug Administration issued an administrative stay Tuesday on the order it issued last month for vaping company to pull its electronic cigarettes from the market.

FILE - An electronic cigarette from Juul Labs is seen on on Feb. 25, 2020, in Pembroke Pines, Fla. Juul has asked a federal court, Friday, June 24, 2022, to block a government order to stop selling its electronic cigarettes. Federal health officials on Thursday, June 23, ordered Juul to pull its electronic cigarettes from the U.S. market, the latest blow to the embattled company widely blamed for sparking a national surge in teen vaping. (AP Photo/Brynn Anderson, File)

WASHINGTON (AP) — The Food and Drug Administration issued an administrative stay Tuesday on the order it issued last month for vaping company Juul to pull its electronic cigarettes from the market.

The agency said on Twitter that the stay temporarily suspends the marketing denial order while it conducts further review, but does not rescind it.

The FDA issued the initial order banning Juul sales on June 23. A day later, a federal appeals court temporarily blocked the government ban.

The initial FDA action was part of a sweeping effort by the agency to bring scientific scrutiny to the multibillion-dollar vaping industry after years of regulatory delays.

To stay on the market, companies must show that their e-cigarettes benefit public health. In practice, that means proving that adult smokers who use them are likely to quit or reduce their smoking, while teens are unlikely to get hooked on them.

The FDA originally said Juul’s application left regulators with significant questions and didn’t include enough information to evaluate any potential health risks. Juul said it submitted enough information and data to address all issues raised.

A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit granted Juul’s request for a hold while the court reviews the case.

On Tuesday, the FDA said it has determined “there are scientific issues unique to the Juul application that warrant additional review.”

Still, it said, the stay and the review do not “constitute authorization to market, sell or ship Juul products.”

Share:

In this article:

Industries:
Consumer Discretionary

Author: AP News

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Originally published by Associated Press Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

Sign up for Investing Intel Newsletter